Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 6671

1.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Aliabadi N, Tate JE, Parashar UD.

Clin Microbiol Infect. 2016 Apr 26. pii: S1198-743X(16)30022-2. doi: 10.1016/j.cmi.2016.03.007. [Epub ahead of print]

PMID:
27129416
2.

Neurodevelopmental delay among children under the age of three years at immunization clinics in Lagos State, Nigeria - Preliminary report.

Bakare MO, Bello-Mojeed MA, Munir KM, Ogun OC, Eaton J.

Sci Rep. 2016 Apr 29;6:25175. doi: 10.1038/srep25175.

PMID:
27125631
3.

Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.

Gabutti G, Franchi M, Maniscalco L, Stefanati A.

Minerva Pediatr. 2016 Jun;68(3):213-25.

PMID:
27125440
4.

B cell development and pneumococcal immunity in vertically-acquired HIV infection.

Eisen S, Hayden C, Young CJ, Gilson R, Jungmann E, Jacobsen MC, Poulsom H, Goldblatt D, Klein NJ, Baxendale HE.

AIDS. 2016 Apr 27. [Epub ahead of print]

PMID:
27124901
5.

Evaluation of the Immune Response to Interferon Gamma Release Assay and Tuberculin Skin Test Among BCG Vaccinated Children in East of Egypt: A Cross-Sectional Study.

Beshir MR, Zidan AE, El-Saadny HF, Ramadan RA, Karam NA, Amin EK, Mohamed MZ, Abdelsamad NM.

Medicine (Baltimore). 2016 Apr;95(17):e3470. doi: 10.1097/MD.0000000000003470.

6.

Early life intranasal colonization with nontypeable Haemophilus influenzae exacerbates juvenile airways disease in mice.

McCann JR, Mason SN, Auten RL, St Geme JW 3rd, Seed PC.

Infect Immun. 2016 Apr 25. pii: IAI.01539-15. [Epub ahead of print]

PMID:
27113355
7.

Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program.

Moreira M, Cintra O, Harriague J, Hausdorff WP, Hoet B.

Vaccine. 2016 Apr 22. pii: S0264-410X(16)30126-8. doi: 10.1016/j.vaccine.2016.04.006. [Epub ahead of print] Review.

PMID:
27113162
8.

Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero<sup>®</sup> to reduce meningococcal group B disease in Germany.

Christensen H, Hellenbrand W, Irving T, Koch J, Trotter CL, Ultsch B, Weidemann F, Wichmann O.

Vaccine. 2016 Apr 21. pii: S0264-410X(16)30124-4. doi: 10.1016/j.vaccine.2016.04.004. [Epub ahead of print]

PMID:
27109566
9.

Factors associated with incomplete or delayed vaccination across countries: A systematic review.

Tauil MC, Sato AP, Waldman EA.

Vaccine. 2016 Apr 22. pii: S0264-410X(16)30145-1. doi: 10.1016/j.vaccine.2016.04.016. [Epub ahead of print] Review.

PMID:
27109562
10.

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

Cabaj JL, Nettel-Aguirre A, MacDonald J, Vanderkooi OG, Kellner JD.

Clin Infect Dis. 2016 Apr 22. pii: ciw175. [Epub ahead of print]

PMID:
27105745
11.

Medicaid Pay for Performance Programs and Childhood Immunization Status.

Hu T, Decker SL, Chou SY.

Am J Prev Med. 2016 May;50(5 Suppl 1):S51-7. doi: 10.1016/j.amepre.2016.01.012.

12.

Pain management during childhood vaccination injections in Portugal - a call to action.

Pacheco SR, Abadesso C, Monteiro A, Taddio A.

Acta Paediatr. 2016 Apr 22. doi: 10.1111/apa.13434. [Epub ahead of print]

PMID:
27102231
13.

Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.

Van Der Meeren O, Behre U, Crasta P.

Vaccine. 2016 Apr 16. pii: S0264-410X(16)30142-6. doi: 10.1016/j.vaccine.2016.04.013. [Epub ahead of print]

14.

Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.

Wang Z, Chen Y, Xie S, Lv H.

PLoS One. 2016 Apr 19;11(4):e0153804. doi: 10.1371/journal.pone.0153804. eCollection 2016.

15.
16.

Psychosocial intervention for children with narcolepsy: Parents' expectations and perceived support.

Kippola-Pääkkönen A, Härkäpää K, Valkonen J, Tuulio-Henriksson A, Autti-Rämö I.

J Child Health Care. 2016 Apr 18. pii: 1367493516643420. [Epub ahead of print]

PMID:
27091954
17.
18.

Cost-effectiveness of next-generation vaccines: The case of pertussis.

Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP.

Vaccine. 2016 Apr 14. pii: S0264-410X(16)30130-X. doi: 10.1016/j.vaccine.2016.04.010. [Epub ahead of print]

PMID:
27087151
19.

Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008-2011.

Dey A, Knox S, Wang H, Beard FH, McIntyre PB.

Commun Dis Intell Q Rep. 2016 Apr 15;40 Suppl:S1-S70.

PMID:
27087017
20.

Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.

Heeke DS, Lin R, Rao E, Woo JC, McCarthy MP, Marshall JD.

Vaccine. 2016 Apr 14. pii: S0264-410X(16)30140-2. doi: 10.1016/j.vaccine.2016.04.012. [Epub ahead of print]

PMID:
27085175
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk